We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Allos Therapeutics, Inc. (MM) | NASDAQ:ALTH | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.83 | 0 | 01:00:00 |
CUSIP
No.
019777101
|
||
1
|
NAMES
OF REPORTING PERSONS
I.R.S.
IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
Felix J.
Baker
|
|
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See
Instructions)
|
(a)
¨
(b)
¨
|
3
|
SEC
USE ONLY
|
|
4
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
United
States
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE
VOTING POWER
-0-
|
6
|
SHARED
VOTING POWER
4,782,909
|
|
7
|
SOLE
DISPOSITIVE POWER
-0-
|
|
8
|
SHARED
DISPOSITIVE POWER
4,782,909
|
9
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,782,909
|
10
|
CHECK BOX IF THE AGGREGATE
AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES
¨
(See
Instructions)
|
11
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW 9
4.6%
|
12
|
TYPE
OF REPORTING PERSON (See Instructions)
IN
|
CUSIP
No.
019777101
|
||
1
|
NAMES
OF REPORTING PERSONS
I.R.S.
IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
Julian C. Baker
|
|
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See
Instructions)
|
(a)
¨
(b)
¨
|
3
|
SEC
USE ONLY
|
|
4
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
United
States
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE
VOTING POWER
-0-
|
6
|
SHARED
VOTING POWER
4,782,909
|
|
7
|
SOLE
DISPOSITIVE POWER
-0-
|
|
8
|
SHARED
DISPOSITIVE POWER
4,782,909
|
9
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,782,909
|
10
|
CHECK BOX IF THE AGGREGATE
AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES
¨
(See
Instructions)
|
11
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW 9
4.6%
|
12
|
TYPE
OF REPORTING PERSON (See Instructions)
IN
|
Item 1(a)
|
Name
of Issuer:
|
Item 1(b)
|
Address
of Issuer’s Principal Executive
Offices:
|
Item 2(a)
|
Name
of Person Filing:
|
Item 2(b)
|
Address
of Principal Business Office or, if None,
Residence:
|
Name
|
Business Address
|
|
Felix
J. Baker
|
667
Madison Avenue
New
York, NY 10065
|
|
Julian
C. Baker
|
667
Madison Avenue
New
York, NY 10065
|
Item 2(c)
|
Citizenship:
|
Item 2(d)
|
Title
of Class of Securities:
|
Item 2(e)
|
CUSIP
Number:
|
Item
3.
|
If
this statement is filed pursuant to §§240.13d-1(b) or (c), check whether
the person filing is
a: N/A
|
Item
4.
|
Ownership.
|
Name
|
Number
of
Shares
|
Percent
of Class
Outstanding
|
||||||
Baker
Bros. Investments II, L.P.
|
989 | 0.0 | % | |||||
667,
L.P.
|
1,199,988 | 1.2 | % | |||||
Baker
Brothers Life Sciences, L.P.
|
3,425,598 | 3.3 | % | |||||
14159,
L.P.
|
113,525 | 0.1 | % | |||||
Baker/Tisch
Investments, L.P.
|
42,809 | 0.0 | % | |||||
Total
|
4,782,909 | 4.6 | % |
Item
5.
|
Ownership
of Five Percent or Less of a Class.
|
Item
6.
|
Ownership
of More than Five Percent on Behalf of Another
Person.
|
Item
7.
|
Identification
and Classification of the Subsidiary Which Acquired the Security Being
Reported on by the Parent Holding Company or Control
Person.
|
Item
8.
|
Identification
and Classification of Members of the
Group.
|
Item
9.
|
Notice
of Dissolution of Group.
|
Item
10.
|
Certification.
|
/s/ Felix J. Baker
|
Felix
J. Baker
|
/s/ Julian C. Baker
|
Julian
C. Baker
|
/s/ Felix J. Baker
|
Felix
J. Baker
|
/s/ Julian C. Baker
|
Julian
C. Baker
|
1 Year Allos Therapeutics, Inc. (MM) Chart |
1 Month Allos Therapeutics, Inc. (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions